These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38760977)

  • 21. Time With Diabetes Distress and Glycemia-Specific Distress: New Patient-Reported Outcome Measures for the Psychosocial Burden of Diabetes Using Ecological Momentary Assessment in an Observational Study.
    Ehrmann D; Schmitt A; Priesterroth L; Kulzer B; Haak T; Hermanns N
    Diabetes Care; 2022 Jul; 45(7):1522-1531. PubMed ID: 35613338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous glucose monitoring versus blood glucose monitoring for risk of severe hypoglycaemia and diabetic ketoacidosis in children, adolescents, and young adults with type 1 diabetes: a population-based study.
    Karges B; Tittel SR; Bey A; Freiberg C; Klinkert C; Kordonouri O; Thiele-Schmitz S; Schröder C; Steigleder-Schweiger C; Holl RW
    Lancet Diabetes Endocrinol; 2023 May; 11(5):314-323. PubMed ID: 37004710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breastfeeding at night is rarely followed by hypoglycaemia in women with type 1 diabetes using carbohydrate counting and flexible insulin therapy.
    Ringholm L; Roskjær AB; Engberg S; Andersen HU; Secher AL; Damm P; Mathiesen ER
    Diabetologia; 2019 Mar; 62(3):387-398. PubMed ID: 30607466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceptability of Continuous Glucose Monitoring in Elderly Diabetes Patients Using Multiple Daily Insulin Injections.
    Volčanšek Š; Lunder M; Janež A
    Diabetes Technol Ther; 2019 Oct; 21(10):566-574. PubMed ID: 31335199
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of a Smartphone Application to Reduce Hypoglycemia in Type 1 Diabetes: A Pilot Study.
    Feuerstein-Simon C; Bzdick S; Padmanabhuni A; Bains P; Roe C; Weinstock RS
    J Diabetes Sci Technol; 2018 Nov; 12(6):1192-1199. PubMed ID: 29291641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
    Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
    Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia.
    Hope SV; Knight BA; Shields BM; Hill AV; Choudhary P; Strain WD; McDonald TJ; Jones AG
    Diabetologia; 2018 Jan; 61(1):66-74. PubMed ID: 28983693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis.
    Jancev M; Vissers TACM; Visseren FLJ; van Bon AC; Serné EH; DeVries JH; de Valk HW; van Sloten TT
    Diabetologia; 2024 May; 67(5):798-810. PubMed ID: 38363342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
    Mellor J; Kuznetsov D; Heller S; Gall MA; Rosilio M; Amiel SA; Ibberson M; McGurnaghan S; Blackbourn L; Berthon W; Salem A; Qu Y; McCrimmon RJ; de Galan BE; Pedersen-Bjergaard U; Leaviss J; McKeigue PM; Colhoun HM
    Diabetologia; 2024 Aug; 67(8):1588-1601. PubMed ID: 38795153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
    Mellor J; Kuznetsov D; Heller S; Gall MA; Rosilio M; Amiel SA; Ibberson M; McGurnaghan S; Blackbourn L; Berthon W; Salem A; Qu Y; McCrimmon RJ; de Galan BE; Pedersen-Bjergaard U; Leaviss J; McKeigue PM; Colhoun HM
    Diabetologia; 2024 Oct; 67(10):2210-2224. PubMed ID: 39037602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterising frailty, metrics of continuous glucose monitoring, and mortality hazards in older adults with type 2 diabetes on insulin therapy (HARE): a prospective, observational cohort study.
    Fung E; Lui LT; Huang L; Cheng KF; Lau GHW; Chung YT; Ahmadabadi BN; Xie S; Lee JSW; Hui E; So WY; Sung JJY; King I; Goggins WB; Chan Q; Järvelin MR; Ma RCW; Chow E; Kwok T
    Lancet Healthy Longev; 2021 Nov; 2(11):e724-e735. PubMed ID: 36098029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose profiles of older adults with type 1 diabetes using sensor-augmented pump therapy in Australia: pre-randomisation results from the ORACL study.
    Trawley S; Ward GM; Vogrin S; Colman PG; Fourlanos S; Grills CA; Lee MH; MacIsaac RJ; Alipoor AM; O'Neal DN; O'Regan NA; Sundararajan V; McAuley SA
    Lancet Healthy Longev; 2022 Dec; 3(12):e839-e848. PubMed ID: 36410370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mobile Momentary Assessment and Biobehavioral Feedback for Adolescents with Type 1 Diabetes: Feasibility and Engagement Patterns.
    Mulvaney SA; Vaala S; Hood KK; Lybarger C; Carroll R; Williams L; Schmidt DC; Johnson K; Dietrich MS; Laffel L
    Diabetes Technol Ther; 2018 Jul; 20(7):465-474. PubMed ID: 29882677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
    Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
    Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent C-peptide is associated with reduced hypoglycaemia but not HbA
    Marren SM; Hammersley S; McDonald TJ; Shields BM; Knight BA; Hill A; Bolt R; Tree TI; Roep BO; Hattersley AT; Jones AG; Oram RA;
    Diabet Med; 2019 Sep; 36(9):1092-1099. PubMed ID: 30955221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal-bolus insulin regimens in treat-to-target trials: A narrative review.
    Russell-Jones D; Bailey TS; Lane W; Mathieu C; Pedersen-Bjergaard U
    Diabet Med; 2024 Jul; 41(7):e15339. PubMed ID: 38679910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymptomatic hypoglycaemia in Type 1 diabetes: incidence and risk factors.
    Henriksen MM; Andersen HU; Thorsteinsson B; Pedersen-Bjergaard U
    Diabet Med; 2019 Jan; 36(1):62-69. PubMed ID: 30368899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.